The University of Iowa Research Foundation (UIRF) - a 501C3 corporation - commercializes University of Iowa developed technologies and inventions through licensing and new venture formation, and manages the subsequent revenue stream.

Seaport Diagnostics, Inc. operates as a biotechnology company which develops treatments for genetically inherited diseases. It also offers DNA Tests for consumers across many categories such as nutrition, fitness, behavior tendencies, skincare, and more; provides consumers access to genetic information via mobile application; and manages human cell bank for future testing on regenerative medical therapies. The company was founded by Scott Schaus, Robin Y. Smith and Kate Blanchard on June 30, 2014 and is headquartered in Boston, MA.

Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that address long-standing unmet needs in oncology. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and rare-cell diagnostics, and is closely advised by an oncologist-led medical steering committee from leading cancer centers across North America and abroad.

IntegenX, Inc. designs, manufactures, and markets automation systems that enable reliable microsample preparation and analysis for the life sciences. It offers Apollo 100, a platform that allows the processing of DNA sequencing reactions; Apollo 200, an integrated sample preparation system for human DNA identification; microfluidics for DNA sequencing, molecular diagnostics, and human identification applications; and Apollo 324 system, a benchtop robotic workstation that automates the construction of DNA fragment libraries for next-generation sequencing. The company was formerly known as Microchip Biotechnologies, Inc. and changed its name to IntegenX, Inc. in March 2010. The company was incorporated in 2003 and is based in Pleasanton, California.

Agtech Products, Inc. operates as an agricultural biotechnology company that engages in the research, development, manufacture, and technical support application of microbiological-based products for animal industry. The company's products include silage inoculants to maintain stored animal feed; livestock waste treatment products to control the decomposition of poultry litter; animal health and nutrition; and OMRI listed products for use in organic animal production. It offers its products for beef/dairy, poultry, swine, equine, and agriculture. Agtech Products, Inc. was formerly known as AgTech Products of Wisconsin, Inc. and it changed its name in June 1999. The company was founded in 1993 and is based in Waukesha, Wisconsin. As of October 31, 2008, Agtech Products, Inc. operates as a subsidiary of Danisco A/S.

Pathway Genomics provides a comprehensive set of genomic testing services across the healthcare spectrum, including tests for general health and wellness, liquid biopsy, pharmacogenomics, hereditary cancer risk and carrier screening. Its general health and wellness tests, including PathwayFit®, Cardiac DNA Insight®, and SkinFit™, equip physicians and patients with genetic information to support lifestyle choices. Liquid biopsy tests, including CancerIntercept™ Detect and Monitor, are non-invasive tests for detection of circulating tumor DNA. Pathway’s pharmacogenomics tests (Mental Health DNA Insight® and Pain Medication DNA Insight®) provide genetic information to help guide selection of optimal medication for management of mental health and pain disorders. Pathway’s hereditary cancer risk tests, including BRCATrue® and ColoTrue®, evaluate genetic factors for future cancer risk. Pathway Genomics Corporation operates a clinical laboratory to provide its commercial genetic testing services to physicians and their patients in the United States and internationally. Pathway Genomics Corporation was incorporated in 2008 and is based in San Diego, California.

Headquartered in San Diego, California, Pfēnex Inc. is a leading biotechnology company focused on recombinant protein expression for a broad range of applications including therapeutic proteins, vaccines, research, reagents and biosimilars. The Company's core technology, Pfēnex Expression Technology™, is a cutting edge protein expression platform that utilizes the BSL-1 microorganism Pseudomonas fluorescens. Pfēnex Expression Technology™ combines an extensive toolbox of expression components with a robotically enabled high throughput parallel strain screening technology, delivering unprecedented speed and success in identifying protein production strains expressing high titers of soluble active protein.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Everist Health, Inc. (EGI) is a personalized medicine company, which develops and commercializes medically unique diagnostics, prognostics and therapeutic selection technologies. EGI is focused on rapidly growing disease areas with major unmet needs, including cancer, cardiovascular disease and metabolic disease (e.g. diabetes). Mission Everist Health is driving growth by developing innovative prognostics with potential for substantive impact on medical and financial outcomes. Our strategy centers on proprietary research and development, targeted acquisitions, and in-licensing. Everist Health is currently developing a range of products aimed at improving treatment outcomes in: • Cardiovascular Disease (CVD) • Metabolic Diseases (e.g. diabetes) • Neurodegenerative Diseases (e.g. Alzheimer’s and Parkinson’s disease) Description Our mission is developing and commercializing molecular assays and sensor technology aimed at improving patient outcomes and cost-efficiency through better-informed clinical decisions. At the core of our success is our evolutionary and proprietary (patent-protected) Evolver technology platform, which accelerates the development of innovative molecular prognostic tests. Utilizing the Evolver technology, Everist Health has developed the AngioDefender CVD diagnostic system; the world’s first non-invasive device that successfully combines patent protected non-invasive sensor technology and a sophisticated software algorithm to quickly and cost effectively help physicians assess the presence of early-stage CVD and atherosclerosis.

Part of The Mcclay Foundation, Almac Diagnostic Services Ltd. is a company headquartered in Craigavon, UK. The firm engages in development of cancer diagnostics.\nThe company says this about itself: Almac Diagnostics is a stratified medicine company specialising in biomarker driven clinical trials. The company, based in Craigavon, UK and Durham, USA has been in existence for over 15 years. Our diagnostic experience spans: Oncology, Immunology, CNS and Infective diseases.

Dow Global Technologies LLC manufactures chemicals such as polymers.

Veridex, LLC, a Johnson & Johnson company, is an organization dedicated to providing physicians and patients with high-value in vitro diagnostic oncology products.Veridex’s products will significantly benefit patients through earlier disease detection, and will enable personalized strategies to improve patient management and outcomes.

Chromocell Corp. engages in the discovery and development of flavors and nutritional ingredients and therapeutic products. It specializes in different areas of taste sensations as well as aroma and fragrance enhancer discovery. The company was founded by Christian Kopfli and Kambiz Shekdar in 2002 and is headquartered in North Brunswick, NJ.

Part of Oracle Corp., Cerner Innovation, Inc. is a company headquartered in the United States specializing in information retrieval services.

Incyte Pharmaceuticals, Inc. engages in the provision of biopharmaceutical services. The company is headquartered in Palo Alto, CA.

Cygene Laboratories Inc., a biotechnology company, develops and commercializes genetic and diagnostic testing, as well as therapies for infectious, genetic, and autoimmune diseases. The company develops proprietary DNA and RNA testing systems for screening, monitoring, and diagnosis of human, veterinary, and plant diseases. The company’s products include Strategic Target Elimination system (STE), an antibody-based technology to clear microbiological, viral, and chemical agents from blood. STE could also act as a pseudo-vaccine, conferring protection to an individual for approximately 60 days.

Companion Dx Reference Lab LLC is a private company headquartered in the United States. The firm provides integrated genomic diagnostic and decision-support services.